Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up

Samer Al Hadidi, Obada Ehab Ababneh, Carolina D. Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert Smith, Susan Panozzo, Daisy Alapat, Michele Cottler-Fox, Guido Tricot, John D. Shaughnessy, Jr., Fenghuang Zhan, Jeffrey Sawyer, Bart Barlogie, Maurizio Zangari, Frits van Rhee

Blood Adv (2024) 8 (3): 703–707.

https://doi.org/10.1182/bloodadvances.2023011601

Published: 2024

Includes: Supplemental data

Journal Articles

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS

Wancheng Guo, Anne Zhan, David E. Mery, Manit N. Munshi, Oussama Makhoul, Clyde Baily, Maurizio Zangari, Guido Tricot, Hongling Peng, John D. Shaughnessy, Jr.

Blood Adv (2023) 7 (21): 6676–6684.

https://doi.org/10.1182/bloodadvances.2023011096

Published: 2023

Includes: Supplemental data

Journal Articles

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis

Farah Mazahreh, Liyan Mazahreh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood Adv (2023) 7 (13): 3069–3074.

https://doi.org/10.1182/bloodadvances.2022009435

Published: 2023

Journal Articles

AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity

Timon A. Bloedjes, Guus de Wilde, Gerarda H. Khan, Timothy C. Ashby, John D. Shaughnessy, Jr., Fenghuang Zhan, Riekelt H. Houtkooper, Richard J. Bende, Carel J. M. van Noesel, Marcel Spaargaren, Jeroen E. J. Guikema

Blood Adv (2023) 7 (9): 1697–1712.

https://doi.org/10.1182/bloodadvances.2022007383

Published: 2023

Includes: Supplemental data